Navidea Biopharmaceuticals Nachrichten und Aktivitäten

Navidea Biopharmaceuticals ist ein Unternehmen, das unter dem Börsenticker NAVB (US) gelistet ist.

Siehe das Organigramm mit seine 7 wichtigsten Führungskräfte

Die meist gesuchten Biographien bei Navidea Biopharmaceuticals

• Dana Moss, Director
• Jill Stefanelli, Director
• John Scott, Vice Chairman of the Board

Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Navidea Biopharmaceuticals nachzuverfolgen.

Navidea Biopharmaceuticals hat 1.824 Konkurrenten , einschließlich Pfizer (USA), Sanofi (Frankreich) und Roche (Schweiz).

Popular M&A news in Pharmazie

• Cyclo Therapeutics hat Rafael Holdings erworben (veröffentlicht am 28, April 2025).
• Chimerix and Chimerix have merged  (veröffentlicht am 22, April 2025)..
• Imbria Pharmaceuticals hat gerade eine Spendenaktion von 58 Millionen Dollar angekündigt. (veröffentlicht am 10, April 2025).

Andere vorgeschlagene Kontakte der Pharmazie branche

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets bei Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer bei Adare Pharmaceuticals
• Seth Harrison - Chairman and Director bei Braeburn Pharmaceuticals

Mehr über die Pharmazie branche erfahren

Neueste Pressemitteilungen nach Navidea Biopharmaceuticals

• Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024 :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024 :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination :: Navidea Biopharmaceuticals, Inc. (NAVB)
• Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities :: Navidea Biopharmaceuticals, Inc. (NAVB)
• View more press releases Close

Social media about Navidea Biopharmaceuticals

• Navidea Biopharmaceuticals auf Wikipedia, Google News & Yahoo Finance
• Navidea Biopharmaceuticals auf LinkedIn, Twitter & YouTube